POSTER SESSION I Monday, February 28, 2005   —  9:30 AM - 12:00 Noon Convention Center, Exhibit Hall B CYTOPATHOLOGY 37 Differences in High Risk Human Papilloma Virus Testing Results in Pregnant and Non-Pregnant Women with Atypical Squamous Cells of Undetermined Significance (270) ES Campenot, JF Shikle, MY Lin - Naval Medical Center San Diego, San Diego, CA 38 Ultrasound-Guided Fine Needle Aspiration Biopsy of Thyroid Lesions: A 5-Year Experience (272) L Chen, AM Maslan, WA Reeves, RM DeMay - University of Chicago, Chicago, IL 39 Cytologic Features of Urothelial Carcinoma in Instrumented Urines with Cellular Fragments (279) MM El-Fakharany, PF Mazzara - St John Hospital, Detroit, MI 40 Molecular Pathology Evaluation of Indeterminate Common Bile Duct Brushing Cytology Specimens (289) OE Gologan, S Finkelstein, YL Liu, O Lapkus, PA Swalsky, M Wilson, JF Silverman - Allegheny General Hospital, Pittsburgh, PA; RedPath Integrated Pathology, Pittsburgh, PA 41 Integrated Molecular Pathology Evaluation of Pancreatic Brush Cytology (309) O Lapkus, YL Liu, M Leon, PA Swalsky, M Wilson, SD Finkelstein, JF Silverman - Allegheny General Hospital, Pittsburgh, PA; RedPath Integrated Pathology, Pittsburgh, PA 42 What Is the Significance of a Negative FISH in Patients with Atypical Urine Cytology? (310) S Latif, ML Nordberg, D Veillon, S Martin, GA Herrera, EA Turbat-Herrera - Louisiana State University Health Sciences Center, Shreveport, LA 43 Reflex Testing for HPV by Hybrid Capture HCII in Women Less Than 20 Years of Age Strongly Supports the Need for Testing in This Age Group (311) S Latif, J Matthews-Greer, D Rivette, B Meeks, R Reyes, JA Bocchini, EA Turbat-Herrera - Louisiana State University Health Sciences Center, Shreveport, LA 44 Role of NMP-22 in Atypical Urine Cytology: Do We Have a Silver Bullet? (316) I Mansoor, RR Calam, EW Schervish, B Al-Khafaji - St. John Hospital and Medical Center, Detroit, MI 45 Improving the Quality of Cytopathology Practice: Root Cause Analysis of False Negative Diagnoses in Thyroid FNA (324) L Nodit, NP Ohori, D Sudilovsky, SS Raab - University of Pittsburgh Medical Center, Pittsburgh, PA 46 HPV Test Should Be Requested in High-Risk Patients as an "Anticipatory" Positive Test (326) V Padmanabhan, H Farghaly, LQ DuBose, L Christiansen, RS Hoda - Medical University of South Carolina, Charleston, SC 47 Altered Recognition of Reparative Changes in ThinPrep® Specimens in the College of American Pathologists Gynecologic Cytology Program (346) TM Snyder, AA Renshaw, PE Styer, DR Mody, TJ Colgan - College of American Pathologist (CAP); The Methodist Hospital, Houston, TX; Baptist Hospital of Miami, Miami, FL; CAP; Mount Sinai, Toronto, ON, Canada 48 ASC-H: Correlation with Reflex HC2 HPV DNA Test and Biopsy Findings (351) S Taraif, MT Siddiqui, AM West, W Griffith, W Kabbani, C Werner, R Ashfaq - University of Texas Southwestern Medical Center, Dallas, TX 49 Focusing Urovysion on Screening Urine Cytology (357) JL Wise, SL Wenger, BS Ducatman, JE Coad - West Virginia University, Morgantown, WV 50 WT1, Monoclonal CEA, TTF1, and CA 125 Antibodies in the Differential Diagnosis of Lung, Breast and Ovarian Adenocarcinomas in Serous Effusions (365) W Zhu, CW Michael - University of Michigan Hospitals, Ann Arbor, MI